- Home
- EPAC vs NVCR Comparison
EPAC vs NVCR Comparison
Compare EPAC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- NVCR
- Stock Information
- Founded
- EPAC 1910
- NVCR 2000
- Country
- EPAC United States
- NVCR Switzerland
- Employees
- EPAC N/A
- NVCR N/A
- Industry
- EPAC Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- EPAC Technology
- NVCR Health Care
- Exchange
- EPAC Nasdaq
- NVCR Nasdaq
- Market Cap
- EPAC 2.4B
- NVCR 2.3B
- IPO Year
- EPAC N/A
- NVCR 2015
- Fundamental
- Price
- EPAC $45.77
- NVCR $20.18
- Analyst Decision
- EPAC
- NVCR Buy
- Analyst Count
- EPAC 0
- NVCR 5
- Target Price
- EPAC N/A
- NVCR $33.40
- AVG Volume (30 Days)
- EPAC 338.7K
- NVCR 1.1M
- Earning Date
- EPAC 03-24-2025
- NVCR 05-01-2025
- Dividend Yield
- EPAC 0.09%
- NVCR N/A
- EPS Growth
- EPAC 63.65
- NVCR N/A
- EPS
- EPAC 1.65
- NVCR N/A
- Revenue
- EPAC $592,736,000.00
- NVCR $605,220,000.00
- Revenue This Year
- EPAC $7.71
- NVCR $3.41
- Revenue Next Year
- EPAC $7.87
- NVCR $9.24
- P/E Ratio
- EPAC $29.14
- NVCR N/A
- Revenue Growth
- EPAC N/A
- NVCR 18.82
- 52 Week Low
- EPAC $32.28
- NVCR $11.70
- 52 Week High
- EPAC $51.91
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- EPAC 53.45
- NVCR 41.21
- Support Level
- EPAC $43.37
- NVCR $17.10
- Resistance Level
- EPAC $46.52
- NVCR $22.30
- Average True Range (ATR)
- EPAC 1.17
- NVCR 1.16
- MACD
- EPAC -0.15
- NVCR 0.03
- Stochastic Oscillator
- EPAC 58.54
- NVCR 56.45
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.